Biogen Inc.

12/22/2025 | Press release | Distributed by Public on 12/22/2025 12:30

Biogen Issues Statement in Response to the Passing of Charles Weissmann, MD, Ph.D., Co-Founder of Biogen

Biogen shares its deepest condolences on the passing of Charles Weissmann, MD, Ph.D., a visionary scientist and one of the cofounders of Biogen. As a pioneer in biotechnology, Dr. Weissman played a foundational role in shaping Biogen during its earliest days and helped place it into history as one of the world's first biotechnology companies. Dr. Weissmann's scientific insight, entrepreneurial spirit and commitment to advancing biology and medicine left a lasting mark on Biogen and on the biotechnology industry as a whole, helping lay the groundwork for decades of innovation and scientific progress. Our sympathy goes out to Charles' family, friends and colleagues. We will continue to honor his legacy and remain grateful for his impact on our past and future as a company.

Biogen Inc. published this content on December 22, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on December 22, 2025 at 18:30 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]